News
ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M
June 29, 2022
Read MoreOdyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines
December 07, 2021
Read MoreRumble Inc., The Neutral Video Platform, to go Public Through Combination With Cantor Fitzgerald's CF Acquisition Corp. VI (Nasdaq: CFVI)
December 01, 2021
Read MoreReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million
October 21, 2021
Read MoreEBY - The Authority in Seamless Underwear - Announces $6 Million in Series A Funding and the Launch of their Limited Edition Seamless Luxe Collection
August 30, 2021
Read MoreRocket Pharmaceuticals Announces Positive Gene Expression, Clinical Biomarker and Preliminary Functional Data from Phase 1 Trial of RP-A501 for the Treatment of Danon Disease
December 8, 2020
Read MoreReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing
March 26, 2020
Read More